TABLE 2.
Virus RNA in saliva, NPs, and ANs samples and sensitivities
| Subject or virus | No. with positive specimen result: |
Sensitivity (%) |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Saliva+/AN+/NP+ | Saliva+/AN−/NP+ | Saliva+/AN−/NP− | Saliva+/AN+/NP− | Saliva−/AN+/NP+ | Saliva−/AN−/NP+ | Saliva | AN | NP | |
| Global (n = 92) | 72 | 6 | 8 | 1 | 3 | 2 | 94.6 | 82.6 | 90.2 |
| Asymptomatic (n = 21) | 13 | 2 | 2 | 1 | 1 | 2 | 85.7 | 71.4 | 85.7 |
| Symptomatic <5 days (n = 59) | 49 | 4 | 6 | 0 | 0 | 0 | 100 | 83.1 | 89.8 |
| Symptomatic ≥5 days (n = 12) | 10 | 0 | 0 | 0 | 2 | 0 | 83.3 | 100 | 100 |
| BA.1 (n = 65) | 51 | 4 | 6 | 1 | 2 | 1 | 95.4 | 83.1 | 89.2 |
| BA.2 (n = 24) | 21 | 1 | 1 | 0 | 1 | 0 | 95.8 | 91.7 | 95.8 |